Targeting antibiotic resistance: molecular dissection of a mitotic machine driving genome segregation in Enterococcus

针对抗生素耐药性:驱动肠球菌基因组分离的有丝分裂机器的分子解剖

基本信息

  • 批准号:
    G0500588/1
  • 负责人:
  • 金额:
    $ 37.11万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2006
  • 资助国家:
    英国
  • 起止时间:
    2006 至 无数据
  • 项目状态:
    已结题

项目摘要

When antibiotics were first identified and developed in the middle of the previous century, it was thought that they would signal an end to many bacterial infectious diseases. To the present day, antibiotics have saved the lives and eased the suffering of countless millions of people. However, in recent decades antibiotic resistant bacteria have emerged inexorably. Of particular concern are those bacteria that acquire resistance to multiple antibiotics as infections caused by these strains can be particularly difficult to treat. The group of bacteria known as enterococci were previously considered to be harmless, perhaps even beneficial, inhabitants of the human gut and many other environments. However, in recent years enterococci have emerged as significant sources of disease among hospital patients who are specially vulnerable to infection. Furthermore, infectious enterococci are often resistant to antibiotics but also are a worrying source of antibiotic resistance spread to other bacteria such as methicillin-resistant Staphylococcus aureus (MRSA). Although most of the biochemical processes involved in making bacterial cells, like those of enterococci, are determined by genes located on the bacterial chromosome, many bacteria also harbour accessory elements termed plasmids that can contribute to the genetic make-up of a bacterium. Plasmids are also of considerable medical significance because antibiotic resistance genes are commonly located on these elements which can be transferred rapidly between bacteria thereby leading to the spread of antibiotic resistance. Plasmids have developed genetic strategies that ensure their maintenance within bacteria. This research proposal focuses on an examination of a maintenance system from an antibiotic resistance plasmid in the enterococcus bacterium with a view to enhancing our understanding of how these elements are stably inherited in bacterial populations. By learning more about how plasmids are maintained within bacteria, we hope in the longer term to be able to devise strategies that can be used to destabilize them, thus producing novel antibacterial agents.
当抗生素在上个世纪中叶首次被发现和开发时,人们认为它们将标志着许多细菌传染病的终结。时至今日,抗生素挽救了无数人的生命,减轻了无数人的痛苦。然而,近几十年来,抗药性细菌的出现势不可挡。特别令人担忧的是那些对多种抗生素产生抗药性的细菌,因为这些菌株引起的感染可能特别难以治疗。这种被称为肠球菌的细菌以前被认为是无害的,甚至可能是有益的,居住在人类肠道和许多其他环境中。然而,近年来,肠球菌已经成为医院患者的重要疾病来源,他们特别容易受到感染。此外,感染性肠球菌通常对抗生素具有耐药性,但也是向其他细菌传播抗生素耐药性的令人担忧的来源,如耐甲氧西林金黄色葡萄球菌(MRSA)。尽管像肠球菌一样,制造细菌细胞所涉及的大多数生化过程都是由位于细菌染色体上的基因决定的,但许多细菌也含有被称为质粒的辅助成分,这些成分可以对细菌的遗传构成做出贡献。由于抗生素耐药基因通常位于这些元件上,这些元件可以在细菌之间快速转移,从而导致抗生素耐药性的传播,因此质粒也具有相当的医学意义。质粒已经开发出确保它们在细菌中保持的遗传策略。这项研究的重点是检查肠球菌中抗生素耐药质粒的维持系统,以期加强我们对这些元件如何在细菌群体中稳定遗传的理解。通过更多地了解质粒在细菌中是如何维持的,我们希望从长远来看,能够设计出可以用来破坏它们稳定的策略,从而生产出新的抗菌剂。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Finbarr Hayes其他文献

The bacterial segrosome: a dynamic nucleoprotein machine for DNA trafficking and segregation
细菌隔离子体:一种用于 DNA 运输和分离的动态核蛋白机器
  • DOI:
    10.1038/nrmicro1342
  • 发表时间:
    2006-02-01
  • 期刊:
  • 影响因子:
    103.300
  • 作者:
    Finbarr Hayes;Daniela Barillà
  • 通讯作者:
    Daniela Barillà
Aberystwyth University Terminator Operon Reporter
亚伯大学终结者操纵子记者
  • DOI:
  • 发表时间:
    2016
  • 期刊:
  • 影响因子:
    0
  • 作者:
    M. Zampini;Luis A. J. Mur;P. Stevens;J. Pachebat;C. Newbold;Finbarr Hayes;Alison H. Kingston
  • 通讯作者:
    Alison H. Kingston
Disentangling gene networks
解开基因网络
  • DOI:
    10.1038/nchembio.1983
  • 发表时间:
    2015-12-17
  • 期刊:
  • 影响因子:
    13.700
  • 作者:
    Finbarr Hayes
  • 通讯作者:
    Finbarr Hayes

Finbarr Hayes的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Finbarr Hayes', 18)}}的其他基金

Building the segrosome a nucleoprotein machine that drives bacterial DNA segregation
构建 Segrosome 驱动细菌 DNA 分离的核蛋白机器
  • 批准号:
    BB/G003114/1
  • 财政年份:
    2008
  • 资助金额:
    $ 37.11万
  • 项目类别:
    Research Grant

相似国自然基金

水环境中新兴污染物类抗生素效应(Like-Antibiotic Effects,L-AE)作用机制研究
  • 批准号:
    21477024
  • 批准年份:
    2014
  • 资助金额:
    86.0 万元
  • 项目类别:
    面上项目

相似海外基金

Targeting KLF2 in macrophages to improve immune checkpoint therapy for hepatocellular cancer
靶向巨噬细胞中的 KLF2 以改善肝细胞癌的免疫检查点治疗
  • 批准号:
    10677187
  • 财政年份:
    2023
  • 资助金额:
    $ 37.11万
  • 项目类别:
Metagenomic discovery and optimization of novel endolysins targeting Cutibacterium acnes to treat acne vulgaris
针对痤疮皮肤杆菌治疗寻常痤疮的新型内溶素的宏基因组发现和优化
  • 批准号:
    10821291
  • 财政年份:
    2023
  • 资助金额:
    $ 37.11万
  • 项目类别:
FimH-Targeting Antibody-Recruiting Molecules as Novel Drugs for Preventing Complicated Urinary Tract Infections
FimH 靶向抗体招募分子作为预防复杂性尿路感染的新药
  • 批准号:
    10603693
  • 财政年份:
    2023
  • 资助金额:
    $ 37.11万
  • 项目类别:
Targeting antibiotic resistance: the importance of genome segregation
针对抗生素耐药性:基因组分离的重要性
  • 批准号:
    2887465
  • 财政年份:
    2023
  • 资助金额:
    $ 37.11万
  • 项目类别:
    Studentship
Targeting T3SA proteins as protective antigens against Yersinia
将 T3SA 蛋白作为针对耶尔森氏菌的保护性抗原
  • 批准号:
    10645989
  • 财政年份:
    2023
  • 资助金额:
    $ 37.11万
  • 项目类别:
2023 Multi-Drug Efflux Systems: Targeting the Mechanisms and Regulation of Multi-Drug Transporters for Advancing Health during a Pandemic GRC/GRS
2023 多药物外排系统:针对多药物转运蛋白的机制和调节,以在大流行 GRC/GRS 期间促进健康
  • 批准号:
    10614335
  • 财政年份:
    2023
  • 资助金额:
    $ 37.11万
  • 项目类别:
Development of a Dual-Targeting ClpP Activating Antibiotic
双靶点 ClpP 激活抗生素的开发
  • 批准号:
    10760586
  • 财政年份:
    2023
  • 资助金额:
    $ 37.11万
  • 项目类别:
Developing novel pyrazolidinone antibiotics targeting PBP3 to overcome resistance mechanisms
开发针对 PBP3 的新型吡唑烷酮抗生素以克服耐药机制
  • 批准号:
    10590839
  • 财政年份:
    2023
  • 资助金额:
    $ 37.11万
  • 项目类别:
Developing a novel class of peptide antibiotics targeting carbapenem-resistant Gram-negative organisms
开发一类针对碳青霉烯类耐药革兰氏阴性生物的新型肽抗生素
  • 批准号:
    10674131
  • 财政年份:
    2023
  • 资助金额:
    $ 37.11万
  • 项目类别:
Enabling Rational Design of Drug Targeting Protein-Protein Interactions with Physics-based Computational Modeling
通过基于物理的计算模型合理设计靶向药物的蛋白质-蛋白质相互作用
  • 批准号:
    10710974
  • 财政年份:
    2023
  • 资助金额:
    $ 37.11万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了